Lec 2- Cards


INTRODUCTION

This lecture addresses the topics of overweight, obesity, and sleep apnoea. It focuses on the definitions, classifications, aetiology, pathophysiology, co-morbidities, and treatment strategies associated with these conditions.

LEARNING OUTCOMES

By the end of this lecture, students should be able to:

  • Describe the aetiology and pathophysiology of obesity.

  • Identify co-morbidities associated with obesity and treatment strategies for weight loss.

  • Describe the aetiology and pathophysiology of sleep apnoea.

  • Identify co-morbidities and treatment strategies for sleep apnoea.

OVERWEIGHT AND OBESITY
Definitions
  • Overweight: Refers to any weight that exceeds a standard or reference value.

  • Obesity: Characterized by excessive body fat that poses a significant risk to health. It is commonly classified using the Body Mass Index (BMI).

Body Mass Index (BMI)
  • BMI Formula:
    BMI=weight (kg)height (m)2\text{BMI} = \frac{\text{weight (kg)}}{\text{height (m)}^2}

  • Body composition and waist circumference are critical for refining obesity classification and determining associated health risks.

DIAGNOSIS AND CLASSIFICATION
Limitations of BMI Alone

While BMI provides a useful measure of obesity, relying solely on it can be misleading. Factors such as waist circumference and body composition must be considered for a more accurate health risk assessment.

BMI Values and Classification
  • Includes categories from Underweight to Morbidly Obese based on BMI and percentage over ideal weight:

    Category

    BMI

    % over ideal weight*

    Disease risk

    % fat** and waist circumference in inches

    Underweight

    <18.5

    NA

    <20


    Normal

    18.5-24

    0%-10%

    20-25


    Overweight

    25-29

    10%-20%

    26-31


    Mild Obesity

    30-34

    20%-40%

    32-37


    Moderate Obesity

    35-39

    40%-100%

    38-45


    Morbidly Obese

    ≥40

    >100%

    >45


  • Weight is a percentage over standard height-weight tables.
    ** Fat percentage is calculated and expressed as a percentage of total weight. Guidelines suggest men are at the lower end and women at the upper end of the ranges.

SCOPE OF OBESITY
Global Prevalence
  • The worldwide prevalence of obesity has nearly tripled since 1975:

    • In 2016, there were more than 1.9 billion adults classified as overweight.

    • Of these, 650 million were considered obese.

    • Additionally, around 41 million children under the age of 5 were overweight or obese, and more than 340 million children and adolescents aged 5-19 were also overweight or obese.

    • Source: WHO Fact Sheets on obesity.

Overweight Rates by Country (1972-2016)
  • A graph illustrates the rates of overweight (including obesity) over time in various countries, indicating trends that display a general increase in obesity rates globally.

AETIOLOGY AND PATHOPHYSIOLOGY
Core Causes
  • Obesity is characterized by a longstanding positive energy balance where energy intake exceeds energy expenditure.

Contributing Factors
  1. Environmental and Behavioral Factors: These include easy access to food, eating habits, levels of physical activity, and stress factors.

  2. Genetic Influences: Genetics play a crucial role in both baseline metabolic rate and fat distribution patterns.

  3. Basal Metabolic Rate (BMR): This determines the amount of energy expended while at rest and affects how one gains or loses weight based on activity levels and diets.

Leptin's Role in Body Mechanics
  • Leptin: A hormone produced by adipocytes (fat cells).

    • Plasma leptin concentrations correlate with adipose tissue mass; it serves a critical role in regulating appetite by promoting satiety.

    • An increase in fat mass leads to elevated leptin levels, which can result in lowered hypothalamic leptin sensitivity (essentially causing leptin resistance), resulting in increased appetite and decreased metabolism.

CO-MORBIDITIES ASSOCIATED WITH OBESITY
  1. Cardiovascular Disease: Includes coronary and peripheral artery diseases linked to increased pro-inflammatory adipokines, elevated LDL levels, and increased blood pressure.

  2. Glucose Intolerance: Can contribute to diabetes and insulin resistance.

  3. Hypertension: High blood pressure is commonly associated with obesity-related conditions.

  4. Dyslipidaemia: Abnormal lipid profiles develop, increasing cardiovascular risks.

  5. Sleep Apnoea: Relates to breathing irregularities during sleep.

  6. Osteoarthritis: Joints are negatively affected by excess weight.

  7. Certain Cancers and Depression: Psychological impacts may also be correlated with physical health conditions.

Impact of Fat Distribution
  • The risk of co-morbidities is significantly affected by whether individuals possess android (central) or gynoid (lower body) obesity. Android obesity, for example, frequently indicates higher risk for metabolic derangements and cardiovascular disease while gynoid obesity has generally lower risk factors associated.

TREATMENT STRATEGIES
General Recommendations

The National Institutes of Health (NIH) suggests a target of 10% weight loss over a duration of 6-12 months for substantial health benefits across several parameters:

  • Blood Pressure: 10 mmHg decline in systolic and diastolic blood pressure among hypertensive patients.

  • Diabetes Management: Up to 50% reduction in fasting glucose for newly diagnosed patients.

  • Improved Insulin Sensitivity: Notable improvement for prediabetic patients, potentially more than 30%.

  • Lipid Profile Improvement: Expect a 10-15% reduction in total cholesterol and triglycerides, which elevates HDL cholesterol levels significantly.

  • Mortality Risk: There is a over 20% decline in all-cause mortality and upwards of 40% in deaths specifically tied to obesity or diabetes.

Treatment Modalities
  1. Diet/Nutritional Therapy: Establishing a negative energy balance where energy intake is less than energy expenditure is critical. A general guideline may recommend a 2500 kJ daily deficit.

  2. Behavior Change Strategies: Employing accountability, problem-solving skills, and motivation are vital in conjunction with dietary approaches.

  3. Exercise Interventions: The significance of combined efforts is emphasized in effecting both considerable weight loss and effective maintenance post-loss.

  4. Pharmacological Therapies: May include appetite suppressants or cholesterol lowering medications, but potential side effects such as gastrointestinal discomfort must be noted.

  5. Surgical Therapies: For individuals with severe obesity (BMI > 40 or > 35 with co-morbidities), surgical interventions like gastric banding or intestinal bypass may be recommended.

Exercise Recommendations and ACSM Guidelines
  • Aerobic Exercise:

    • Frequency: At least 5 days per week.

    • Intensity: Start with moderate (40%-59% VO₂R) progressing to vigorous.

    • Duration: Minimum 30 minutes daily with the aim to increase to 60 minutes or more.

    • Type: Activities should involve major muscle groups such as walking or cycling.

  • Resistance Training:

    • Frequency: 2-3 days per week targeting all major muscle groups.

    • Intensity: 60%-70% of one-rep max with sets of 8-12 repetitions.

  • Flexibility Training:

    • Frequency: At least 2-3 days per week with static stretches held for 10-30 seconds.

SLEEP APNOEA
Definition

Characterized by recurrent partial or complete collapse of the upper airway during sleep, sleep apnoea is a significant medical condition affecting respiratory function.

Signs and Symptoms
  • Daytime sleepiness and fragmented sleep patterns.

  • Snoring with potential pauses and gasps during sleep.

  • Cognitive dysfunction impacting executive function and working memory, alongside low moods or anxiety.

Prevalence
  • Globally, obstructive sleep apnoea affects approximately 1 billion people; while this number may underestimate actual occurrences, it often goes unrecognized. It's notably more prevalent in older, overweight males.

Diagnosis




  • Polysomnography (Sleep Study):


    • This assessment captures brain activity, eye and muscle movements, heart rhythms, and respiratory metrics, thereby revealing the presence and severity of sleep apnoea measured by the Apnoea-Hypopnea Index (AHI).

    • Definitions include Apnoea (no airflow for at least 10 seconds) and Hypopnea (reduced airflow for at least 10 seconds with associated oxygen desaturation or arousal).




  • AHI classifications are categorized as follows:


    Apnea Severity

    AHI (Events/Hour of Sleep)



    Normal

    <5



    Mild

    5 ≤ AHI < 15



    Moderate

    15 ≤ AHI < 30



    Severe

    ≥30





    Pathophysiology



    • During sleep, a natural reduction in muscle tone alongside relaxation of the tongue and soft palate can lead to impaired airflow and subsequent oxygen deprivation and increased carbon dioxide retention, driving cyclic breathing interruptions and cardiovascular strain.

    Co-Morbidities Associated with Sleep Apnoea
    • Obesity, hypertension, cardiac arrhythmias, depression, type 2 diabetes, and hypercholesterolaemia are critical conditions that coincide with sleep apnoea, reinforcing the importance of comprehensive assessments in affected patients.

    TREATMENT FOR SLEEP APNOEA
    1. Continuous Positive Airway Pressure (CPAP): Involves a mask and pump that ensure pathway patency during sleep. Compliance with this therapy can be challenging for patients.

    2. Weight Loss: Reduces the frequency of apnoeas.

    3. Oral Appliances: Intended for repositioning the mandible or tongue to maintain airway open.

    4. Surgical Interventions: Includes correcting anatomical deformities or removing obstructions such as tonsils.

    REVIEW QUESTIONS
    • What is the primary sign or symptom of sleep apnoea?

    • Why is the prevalence of sleep apnoea likely underestimated?

    • How is sleep apnoea diagnosed?

    • What is the most common treatment modality for moderate to severe sleep apnoea? 1. **What is the primary sign or symptom of sleep apnoea?** - The primary signs and symptoms of sleep apnoea include daytime sleepiness, fragmented sleep patterns, and snoring with potential pauses and gasps during sleep. 2. **Why is the prevalence of sleep apnoea likely underestimated?** - The prevalence of sleep apnoea is likely underestimated because it often goes unrecognized, despite affecting approximately 1 billion people globally, and many individuals do not report symptoms or seek help. 3. **How is sleep apnoea diagnosed?** - Sleep apnoea is diagnosed using polysomnography (sleep study), which measures brain activity, eye and muscle movements, heart rhythms, and respiratory metrics to reveal the presence and severity of sleep apnoea, quantified by the Apnoea-Hypopnea Index (AHI). 4. **What is the most common treatment modality for moderate to severe sleep apnoea?** - The most common treatment modality for moderate to severe sleep apnoea is Continuous Positive Airway Pressure (CPAP) therapy, which involves a mask and pump to keep the airway open during sleep.

    This comprehensive overview serves as a detailed educational resource on the intertwined issues of overweight, obesity, and sleep apnoea, facilitating a greater understanding of their complexities and treatment options.